Introducing Cochrane Brain, Nerves and Mind

Message from Cochrane Brain, Nerves and Mind’s Senior Editor, Professor Christopher Eccleston. 

Welcome to Cochrane Brain, Nerves and Mind, one of Cochrane’s Review Group Networks launching in 2018.

The formation of this thematic network is part of Cochrane’s CRG Transformation Programme, which sets out the changes we will be making to ensure Cochrane addresses the challenges it faces in relation to the production of a comprehensive collection of timely, high-quality reviews, relevant to our stakeholders.

Our Networks provide an opportunity to optimize leadership and support at a new editorial level within Cochrane. Cochrane Brain, Nerves, and Mind consists of nine Cochrane Review Groups:

  •         Common Mental Disorders
  •         Dementia and Cognitive Improvement
  •         Developmental, Psychosocial and Learning Problems
  •         Drugs and Alcohol
  •         Epilepsy
  •         Movement Disorders
  •         Multiple Sclerosis and Rare Diseases of the CNS
  •         Neuromuscular
  •         Schizophrenia

These Cochrane Review Groups will work together to produce systematic reviews that cover many topics relating to brain, nerve, and mind conditions, and to assist decision-makers to access and use Cochrane evidence in their work. Cochrane Brain, Nerves and Mind aims to provide the best source of accurate and up-to-date information, especially about the prevention, early detection, and treatments for anyone diagnosed with relevant conditions.

I am delighted to be sharing our new Network with you, together with our reviews, knowledge and resources across many topics in line with Cochrane’s mission of promoting evidence-based medicine for health decision-making across the world.

My best wishes,

Professor Christopher Eccleston
Senior Editor
Cochrane Brain, Nerves and Mind